Dose Escalation Optimization in Patients With Locally Advanced Non-Small-Cell Lung Cancer: The Right Dose, in the Right Location, to the Right Patient, at the Right Time

Jing Zeng¹, Ramesh Rengan^{1

2

3}

Affiliations

¹ Department of Radiation Oncology, University of Washington School of Medicine, Seattle.
² SCCA Proton Therapy, Seattle, Washington.
³ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Comment

Jing Zeng et al. JAMA Oncol. 2017.

. 2017 Oct 1;3(10):1365-1367.

doi: 10.1001/jamaoncol.2017.1344.

Jing Zeng¹, Ramesh Rengan^{1

2

3}

¹ Department of Radiation Oncology, University of Washington School of Medicine, Seattle.
² SCCA Proton Therapy, Seattle, Washington.
³ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

No abstract available

Comment on

Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP. Kong FM, et al. JAMA Oncol. 2017 Oct 1;3(10):1358-1365. doi: 10.1001/jamaoncol.2017.0982. JAMA Oncol. 2017. PMID: 28570742 Free PMC article. Clinical Trial.